Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.50 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | CALML3 | P27482 | 1/20 | 0.39 |
| ▸ | SDHA | P31040 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6528456 | 1.00 | F10 (0.50) | F10MAOBMAOACYP11B2GRM2 | |
| SCHEMBL8126460 | 0.88 | MAOA (0.55) | F10MAOBMAOACYP11B2CYP11B1 | |
| SCHEMBL3832132 | 0.86 | F10 (0.48) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL8137777 | 0.86 | ATAD2 (0.55) | F10MAOBMAOACYP11B2GRM2 | |
| SCHEMBL8132054 | 0.85 | F10 (0.47) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL6531646 | 0.85 | F10 (0.43) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL6531649 | 0.85 | F10 (0.43) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL3832955 | 0.84 | F10 (0.50) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL3832952 | 0.84 | F10 (0.50) | F10MAOBMAOAGRM2LMNA | |
| SCHEMBL8118120 | 0.83 | MAOB (0.41) | F10MAOBMAOACYP11B2GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005082897-A1 | OXAZOLIDINONE ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-09-09 | — | — | WO | disclosed |